Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing

Authors not listed

Gulbenkian Institute for Molecular Medicine · 2025

Abstract

AGEWISE is an observational study that aims to understand how changes in gut microbiome are related to hormonal changes during women's ageing, particularly across the different stages of menopause. The study will include healthy women aged 40 to 64 years living in Portugal, who will provide stool and blood samples and complete questionnaires about their health, lifestyle, diet, and menopausal symptoms. Researchers will study the gut microbiome together with hormone levels and markers of inflammation to better understand how menopause affects long-term health and to support the development of improved prevention strategies for women.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Anonymous. (2025). AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing. <em>Gulbenkian Institute for Molecular Medicine</em>. https://clinicaltrials.gov/study/NCT07614542
Vancouver
Anonymous. AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing. Gulbenkian Institute for Molecular Medicine. 2025.
BibTeX
@misc{anon2025AGEWIS, title = {AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing}, author = {Anonymous}, journal = {Gulbenkian Institute for Molecular Medicine}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings